HOME  |  CONTACT  |  SITEMAP   
Home > 교실소개 > 기초의학 > 교수진 명단

| 교수진 명단



  • 김소원 조교수

    약리학

    패스워드가 일치하지 않습니다.

    • 02-3010-4621
    전공분야

    소속연구단

    관련/관심분야

        데이터가 없습니다.

    주요논문

    1. HER2 overexpression predicts pathological T2 stage and improved survival in de novo muscle-invasive bladder cancer after immediate radical cystectomy: a retrospective cohort study [ International Journal of Surgery ] - 2024.02.01
    2. Corticosteroid Antibiotic Interactions in Bacteria that Cause Corneal Infection [ Translational Vision Science & Technology ] - 2023.05.01
    3. Prospective pharmacological methodology for establishing and evaluating anti-cancer drug resistant cell lines [ BMC CANCER ] - 2021.09.28
    4. Impact of Sampling Period on Population Pharmacokinetic Analysis of Antibiotics: Why do You Take Blood Samples Following the Fourth Dose? [ Pharmaceuticals ] - 2020.09.16
    5. Genotypic and Phenotypic Resistance to Clarithromycin in Helicobacter pylori Strains [ Journal of clinical medicine ] - 2020.06.19
    6. Nephrotoxicity of amikacin in noncritically ill patients [ CLINICAL NEPHROLOGY ] - 2019.10.01
    7. A new population pharmacokinetic model for vancomycin in patients with variable renal function: therapeutic drug monitoring based on extended covariate model using CKD-EPI estimation. [ JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS ] - 2019.10.01
    8. Effect of pharmacokinetic model misspecification on antibiotic probability of target attainment predicted by Monte Carlo simulation [ INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS ] - 2019.07.01
    9. Curcumin treatment in combination with glucose restriction inhibits intracellular alkalinization and tumor growth in hepatoma cells. [ INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES ] - 2019.05.14
    10. 10-Phenyltriazoyl artemisinin is a novel P-glycoprotein inhibitor that suppresses the overexpression and function of P-glycoprotein. [ CURRENT PHARMACEUTICAL DESIGN ] - 2018.12.31
    11. Pharmacokinetics of Doripenem in Healthy Koreans and Monte-Carlo Simulations to Explore Optimal Dosage Regimens in Patients with Normal and Enhanced Renal Function. [ THERAPEUTIC DRUG MONITORING ] - 2018.08.01
    12. Role of 14-3-3 sigma in over-expression of P-gp by rifampin and paclitaxel stimulation through interaction with PXR. [ CELLULAR SIGNALLING ] - 2017.02.01
    13. GWAS identifies two susceptibility loci for lamotrigine-induced skin rash in patients with epilepsy. [ EPILEPSY RESEARCH ] - 2015.09.01
    14. Casein Kinase 2 (CK2)-mediated Phosphorylation of Hsp90β as a Novel Mechanism of Rifampin-induced MDR1 Expression. [ JOURNAL OF BIOLOGICAL CHEMISTRY ] - 2015.07.03
    15. A newly discovered LGI1 mutation in Korean family with autosomal dominant lateral temporal lobe epilepsy [ SEIZURE-EUROPEAN JOURNAL OF EPILEPSY ] - 2014.01.01
    16. ABCB1 c.2677G > T Variation Is Associated With Adverse Reactions of OROS-Methylphenidate in Children and Adolescents With ADHD [ JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY ] - 2013.08.01

    연구과제 수주실적

    1. NHE1을 표적으로 하는 새로운 대사항암제 개발 - 2024.03.01 ~ 2025.02.28
    2. 수술 후 보조항암화학요법과 한약제제 병용 투여 시 상승 기전 규명 - 2024.01.01 ~ 2024.12.31
    3. 수술 후 보조항암화학요법과 한약제제 병용 투여 시 상승 기전 규명 - 2023.04.01 ~ 2023.12.31
    4. NHE1을 표적으로 하는 새로운 대사항암제 개발 - 2023.03.01 ~ 2024.02.29
    5. NHE1을 표적으로 하는 새로운 대사항암제 개발 - 2022.03.01 ~ 2023.02.28
    6. 항생제와 스테로이드 병용 투여 최적의 조합을 발굴하기 위한 세포내 약동학적 상호작용 탐구 - 2021.06.01 ~ 2022.05.31
    7. 포도당 제어와 TCA 회로 조절을 통한 항암 치료 효율 증가 기술 개발 - 2021.01.01 ~ 2021.12.31

    특허/기술이전실적

      데이터가 없습니다.

    국내외 경력

          데이터가 없습니다.

     공지